Replies to post #45778 on Avid Bioservices Inc (CDMO)

[MobyInvestor]

That blew up in your face on Thursday when Dr. Robert Garnick said

CG, until I see a PR that details the specifics of whatever the next trial is I reserve the right to assume that Garnick is using the term "bavituximab" generically, not specifically to the current mAb.

If so, then I'll throw in the towel, but not before.

As to my question regarding Peregrine's Oncology pipeline, where do you think we are on that graphic now?

Regards,

moby

[entdoc]

cj, it wouldn't surprise me if this "now-crowd" at PPHM could "pole vault" a fully humanized Bavi onto the stage to take over for current chimeric model. Biosimilars, or sumpin' like that. Let's get real. The medical profession knows it is there. Or at least I do.